equitybuy

LRCX · Lam Research Corporation

Lam Research (LRCX) supplies etch and deposition tools used in advanced semiconductor manufacturing. The company is a direct beneficiary of any credible advanced-node fab buildout and of increased etch/deposition intensity as patterning and 3D structures grow more complex.

Opportunity
88 / 100
Current score
1.46
Thesis calls
8
Active ticker theses
8

Recent proof-backed thesis calls

Recent thematic calls trade the 'AI + capacity buildout' narrative via semiconductor equipment/ETF exposure rather than relying on unverified single-project bets. Commentary around large, speculative fab concepts (e.g., the so‑called 'Terafab') can lift sentiment for equipment names, but such chatter lacks confirmed capex, site, partners, or timelines.

Steve Eismanyoutuberight

Podcast episode description: Steve Eisman interviews Bernstein semiconductor analyst Stacy Rasgon about the AI semiconductor boom (semi sector up ~60% YTD), who is winning (GPU-centric AI leaders and adjacent beneficiaries), who is catching up (AMD/Intel, others), and what could derail the boom (key cited risk: power constraints; also implied: demand/capex cycle risk). No explicit price targets or trade levels provided in the source text.

Mentioned: Jun 8, 2026, 12:00 PM EDTConviction: 52 / 100Observed price: $323.92 on 2026-06-08Return: 91.92%
Source: The AI Semiconductor Boom and What Could End It with Stacy Rasgon | The Real Eisman Playbook Ep 63
LAM RESEARCH CORPsec_filingsright

This excerpt is only the cover/header portion of Lam Research’s Form 10-Q for the quarter ended March 29, 2026. It confirms the filing type, period, exchange listing (Nasdaq), and basic compliance checkboxes, but contains no financial results, guidance, risk-factor updates, or MD&A content to form a directional investment view.

Mentioned: Apr 23, 2026, 4:05 PM EDTConviction: 60 / 100Observed price: $258.56 on 2026-04-23Return: -211.70%
Source: LRCX 10-Q report for 2026-03-29
Anastasi In Techyoutuberight

The source argues that a proposed Texas 'Terrafab' tied to Elon/Tesla-style AI ambitions could attempt leading-edge 2nm, gate-all-around semiconductor manufacturing at huge scale—framed as potentially producing ~1 terawatt of AI chips per year. It emphasizes how difficult this is: only TSMC, Intel, and Samsung remain credible at the leading edge, EUV lithography is scarce and extremely expensive, and manufacturing know-how/process integration is the hidden bottleneck. Market implication: if real

Mentioned: Apr 14, 2026, 8:00 PM EDTConviction: 55 / 100Observed price: $265.16 on 2026-04-15Return: 75.47%
Source: This New Chip Factory Could Save America
ARK Investyoutuberight

Podcast-style discussion of a rumored/aspirational Elon Musk “Terafab” concept—an extremely large semiconductor manufacturing buildout intended to address perceived global chip undersupply. The entry is commentary/speculation rather than a confirmed corporate announcement (no capex figure, site, timeline, partners, or regulatory filings cited), so tradability is mainly thematic (semi capex/equipment) rather than event-driven.

Mentioned: Mar 26, 2026, 4:00 PM EDTConviction: 37 / 100Return: 105.76%
Source: Terafab: Elon’s Plan To Dominate Semiconductors | The Brainstorm EP 124
Anastasi In Techyoutuberight

The source is a promotional/educational chip-industry video centered on Intel’s Fab 52 in Arizona and a claimed leading-edge microchip/process breakthrough, likely referring to Intel’s next-generation foundry roadmap and advanced manufacturing technologies. It frames the Arizona buildout as a strategic race between Intel, TSMC, and Samsung to manufacture advanced semiconductors on U.S. soil. The key investment implication is Intel’s high-upside but high-risk attempt to regain process leadership

Mentioned: Mar 23, 2026, 4:30 PM EDTConviction: 49 / 100Observed price: $233.31 on 2026-03-23Return: 181.89%
Source: Huge Chip Breakthrough — and a Big Warning for All
LAM RESEARCH CORPsec_filingsright

The provided excerpt is only the cover page/filing header of Lam Research’s Form 10-Q for the quarter ended Dec 28, 2025. It contains no financial results, guidance, risks, segment trends, or management commentary—therefore it is not meaningfully actionable for trading beyond confirming the filing exists and LRCX remains listed/compliant.

Mentioned: Jan 29, 2026, 4:16 PM ESTConviction: 60 / 100Observed price: $248.17 on 2026-01-29Return: -211.70%
Source: LRCX 10-Q report for 2025-12-28
LAM RESEARCH CORPsec_filingsright

Excerpt is only the Form 10‑Q cover page for Lam Research (LRCX) for quarter ended Sept 28, 2025. It confirms listing/ticker and routine SEC filing/compliance checks, but contains no financial results, guidance, risks, or MD&A content to derive a directional investment view.

Mentioned: Oct 24, 2025, 4:06 PM EDTConviction: 60 / 100Observed price: $151.68 on 2025-10-24Return: -211.70%
Source: LRCX 10-Q report for 2025-09-28
LAM RESEARCH CORPsec_filingsright

Provided text is only the Form 10-K cover page/filing header for Lam Research (LRCX) for fiscal year ended June 29, 2025. It contains listing/compliance metadata (exchange, ticker, issuer status) but no financial results, guidance, risk-factor changes, segment performance, cash flow, or material disclosures. As-is, it does not support a directional trade thesis beyond confirming normal filing status.

Mentioned: Aug 11, 2025, 4:35 PM EDTConviction: 18 / 100Observed price: $102.00 on 2025-08-11Return: 25.78%
Source: LRCX 10-K report for 2025-06-29

Latest market-close explanation

Research note (2026-04-13): LRCX rose 1.39% to 267.32 with no clear single-stock catalyst. The move appeared sector-driven (semicap 'risk-on') on lighter volume, likely incremental buying rather than headline-driven repricing. Speculative narratives (e.g., 'Terafab') may have supported sentiment but lack confirmation. Watch for real capex signals, Lam earnings/guidance, peer read-throughs, macro/rates, and any tangible evidence that speculative buildout narratives are becoming real.

2026-06-12Move: 1.18%Close: $366.81market

**LRCX** (Lam Research Corporation) moved **+1.18%** on 2026-06-12, closing at **$366.81** after a previous close of **$362.52**. Intraday range was **$354.89** to **$373.82**. Volume changed **-39.1%** versus the prior session. No strong internal catalyst was found, so the move may reflect broader market positioning, sector rotation, or external news flow.

Current stance

Current recommendation: buy. The rationale: Lam is a natural way to play the AI-driven capex narrative through semiconductor equipment exposure rather than through speculation on single, unverified projects (source: https://www.youtube.com/@ARKInvest2015; confidence 0.37).

Recommendationbuy
Authors4
Active ticker theses8
Latest price$366.81
Why now
  • sell via LRCX 10-Q report for 2026-03-29 from https://www.sec.gov/edgar/search/ (confidence 0.60)
  • beneficiary via Semiconductor capital equipment is the most direct beneficiary of any credible new advanced-node fab buildout. from https://www.youtube.com/@AnastasiInTech (confidence 0.56)
  • beneficiary via Stay long the AI semiconductor leaders and the capex toolchain while hyperscaler AI spending remains intact. from https://www.youtube.com/@RealEismanPlaybook (confidence 0.52)

Active and historical ticker theses

Active plays focus on Lam's leverage to advanced-node etch and deposition steps, structural tailwinds from advanced patterning and 3D architectures, and chassis-level exposure to any large fab buildouts. Suggested trade exposure via equipment suppliers or relevant ETFs rather than one-off project bets.

Unlock full asset monitoring

Watch for material capex announcements from major fabs, Lam's next earnings and guidance, and consistent sector moves on normal volume. For thematic exposure, consider semicap suppliers or ETFs rather than betting on single speculative projects.